Osmind

Electronic medical record system for mental health

San Francisco, California, United States

About Osmind

Osmind provides an electronic medical record (EMR) system specifically designed for mental health professionals, including psychiatrists and therapists. The platform features tools for billing, scheduling, patient engagement, and intake forms, all aimed at simplifying the management of mental health practices. It automates the tracking of patient progress through objective measurement tools, making it user-friendly even for those less familiar with technology. Unlike many competitors, Osmind operates on a subscription model and also facilitates patient credit card payments without additional transaction fees, creating a dual revenue stream. The company's goal is to enhance mental health care access and improve treatment outcomes, particularly for patients who have not benefited from traditional therapies, while providing excellent customer support to help practitioners transition smoothly to their system.

San Francisco, CaliforniaHeadquarters
2020Year Founded
$55.4MTotal Funding
SERIES_BCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Professional Development Budget

Risks

Emerging EMR platforms with lower costs could threaten Osmind's market share.
Frequent telehealth regulation changes may increase Osmind's operational costs.
Reliance on Zoom for virtual visits poses risks if service outages occur.

Differentiation

Osmind offers a user-friendly EMR platform tailored for mental health professionals.
The platform integrates APA's diagnostic measures, enhancing precision psychiatry and personalized care.
Osmind's dual revenue model includes subscription fees and competitive patient payment processing.

Upsides

Collaboration with APA enhances Osmind's credibility and access to measurement-based care tools.
The rise of telehealth supports Osmind's integrated virtual visit capabilities.
Growing demand for mental health apps aligns with Osmind's digital offerings expansion.